Երկիր: Ավստրալիա
Լեզու: անգլերեն
Աղբյուրը: Department of Health (Therapeutic Goods Administration)
Methylprednisolone sodium succinate
Pfizer Australia Pty Ltd
Medicine Registered
SOLU-MEDROL ® _Methylprednisolone sodium succinate_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET Please read this leaflet carefully before you start treatment with SOLU-MEDROL. This leaflet answers some common questions about SOLU-MEDROL. It does not contain all the available information and it does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you being treated with SOLU-MEDROL against the benefits it is expected to have for you. Follow the instructions given to you by your doctor and the advice contained in this leaflet. IF YOU HAVE ANY CONCERNS ABOUT BEING TREATED WITH THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT SOLU-MEDROL IS USED FOR Your doctor has prescribed SOLU- MEDROL for the treatment of one or more of the following: • skin diseases • allergic reactions • inflammation of the eyes • respiratory diseases and certain respiratory infections • diseases of the gut (gastrointestinal tract) • multiple sclerosis • rheumatic disorders • diseases of the blood • treatment of certain glandular conditions Your doctor may have prescribed SOLU-MEDROL for another reason. _HOW YOUR MEDICINE WORKS_ Methylprednisolone sodium succinate, the active ingredient in SOLU-MEDROL, belongs to a group of medicines called corticosteroids. SOLU-MEDROL acts in the body by reducing inflammation (pain, swelling, redness and heat), which is one of the body's reactions to injury, and by reducing the body's reaction to infection. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY SOLU- MEDROL HAS BEEN PRESCRIBED FOR YOU. SOLU-MEDROL is available only with a doctor's prescription. There is no evidence that SOLU- MEDROL is addictive. BEFORE YOU START TREATMENT WITH SOLU- MEDROL WHEN YOU MUST NOT TAKE IT • Do not take SOLU-MEDROL if you have an allergy to:SOLU- MEDROL or other medicines containing methylprednisolone • any of the ingredients listed at Կարդացեք ամբողջական փաստաթուղթը
Version: pfpsolmv10813 Supersedes: pfpsolmv10212 Page 1 of 22 PRODUCT INFORMATION SOLU-MEDROL ® AND SOLU-MEDROL ® ACT-O-VIAL (METHYLPREDNISOLONE SODIUM SUCCINATE) POWDER FOR INJECTION For Intravenous or Intramuscular Use Only NAME OF THE MEDICINE Non-proprietary name: methylprednisolone sodium succinate Chemical structure: CAS number: 2375-03-3 Molecular weight: 496.53 DESCRIPTION Methylprednisolone sodium succinate, USP, occurs as a white, or nearly white, odourless, hygroscopic, amorphous solid. It is very soluble in water and in alcohol; it is insoluble in chloroform and is very slightly soluble in acetone. Methylprednisolone sodium succinate is so extremely soluble in water that it may be administered in a small volume of diluent and is especially well suited for intravenous use in situations in which high blood levels of methylprednisolone are required rapidly. SOLU-MEDROL is available in several strengths and packages for intravenous or intramuscular administration. 40 MG ACT-O-VIAL ® SYSTEM - Each mL (when mixed) contains methylprednisolone sodium succinate equivalent to 40 mg methylprednisolone; also 1.6 mg sodium phosphate monobasic (anhydrous); 17.46 mg sodium phosphate dibasic (anhydrous) and 25 mg lactose. 125 MG ACT-O-VIAL SYSTEM - Each 2 mL (when mixed) contains methylprednisolone sodium succinate equivalent to 125 mg methylprednisolone; also 1.6 mg sodium phosphate monobasic (anhydrous) and 17.4 mg sodium phosphate dibasic (anhydrous). 500 MG VIAL WITH DILUENT - Each 8 mL (when mixed as directed) contains methylprednisolone sodium succinate equivalent to 500 mg methylprednisolone; a Կարդացեք ամբողջական փաստաթուղթը